Efficacy of acupoint injection in the treatment of chronic eczema and its influence on peripheral blood T cells  

作　　者：Hui-Hui Gan Gao Yang Ting-Ting Shen 

机构地区：[1]Department of Dermatology,Jinshan Hospital of Fudan University,Shanghai 201508,China

出　　处：《World Journal of Clinical Cases》2024年第17期3019-3026,共8页世界临床病例杂志

基　　金：Supported by Jinshan District Medical and Health Science and Technology Innovation Funding Project,No.2021-3-07.

摘　　要：BACKGROUND Chronic eczema significantly impacts daily life,social interactions,and quality of life;however,no curative treatment has been identified.AIM To determine the clinical efficacy of acupoint injection for chronic eczema and its influence on peripheral blood T cells.METHODS Eighty patients with chronic eczema treated at our hospital between June 2022 and March 2023 were randomly assigned to a control group(n=40),which received conventional Western medicine treatment,or an observation group(n=40),which received routine Western medicine treatment plus acupoint injection of triamcinolone acetonide.Response and adverse reaction rates,as well as differences in the levels of serum cytokines IFN-γ,IL-2,IL-4,and IL-10 before and after treatment were investigated.RESULTS No difference in overall response rates were found between the observation and control groups(100%vs 90%,respectively;P>0.05);however,the observation group had a higher marked response rate than the control group(87.5%vs 52.5%;P<0.05).Both groups had decreased Eczema Area and Severity Index scores and increased pruritus after treatment(P<0.05),particularly in the observation group(P<0.05).The observation group had an adverse reaction rate of 2.5%(1/40),which did not differ significantly from that of the control group(P>0.05).The observation group exhibited higher post-treatment INF-γand IL-2 but lower IL-4 levels than the control group(P<0.05);however,no significant inter-group difference was observed in post-treatment IL-10 levels(P>0.05).CONCLUSION Acupoint injection of triamcinolone acetonide is safe and effective in treating chronic eczema.Its therapeutic mechanism is related to the regulation of peripheral blood T cell levels,inhibition of inflammatory reactions,and mitigation of immune imbalance.

关 键 词：ECZEMA Acupoint injection T cells Immune imbalance 

分 类 号：R758.23[医药卫生—皮肤病学与性病学]